Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3
Clinical trial NCT05222906 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05222906
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-18
- Primary completion
- 2025-10-02
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.